Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David K Williams

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Medicinal Chemistry|August 29, 2007
Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarialsPravin Bendale, Srinivas Olepu, Praveen Kumar Suryadevara, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitorsLouis J Lombardo, Amy Camuso, John Clark, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2008
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitorsZhen-Wei Cai, Donna Wei, Gretchen M Schroeder, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinaseGretchen M Schroeder, Xiao-Tao Chen, David K Williams, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferaseWesley C Van Voorhis, Kasey L Rivas, Pravin Bendale, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2023
Synthesis and biological evaluation of biaryl alkyl ethers as inhibitors of IDO1Jay A Markwalder, Aaron J Balog, David K Williams, et al.
Journal of Medicinal Chemistry|August 12, 2008
Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activitiesKyoung Soon Kim, Liping Zhang, Robert Schmidt, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2006
Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitorsKyoung Soon Kim, Songfeng Lu, Lyndon A Cornelius, et al.
Journal of Medicinal Chemistry|March 6, 2009
Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamilyGretchen M Schroeder, Yongmi An, Zhen-Wei Cai, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Medicinal Chemistry|August 29, 2007
Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarialsPravin Bendale, Srinivas Olepu, Praveen Kumar Suryadevara, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitorsLouis J Lombardo, Amy Camuso, John Clark, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2008
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitorsZhen-Wei Cai, Donna Wei, Gretchen M Schroeder, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinaseGretchen M Schroeder, Xiao-Tao Chen, David K Williams, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferaseWesley C Van Voorhis, Kasey L Rivas, Pravin Bendale, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2023
Synthesis and biological evaluation of biaryl alkyl ethers as inhibitors of IDO1Jay A Markwalder, Aaron J Balog, David K Williams, et al.
Journal of Medicinal Chemistry|August 12, 2008
Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activitiesKyoung Soon Kim, Liping Zhang, Robert Schmidt, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2006
Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitorsKyoung Soon Kim, Songfeng Lu, Lyndon A Cornelius, et al.
Journal of Medicinal Chemistry|March 6, 2009
Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamilyGretchen M Schroeder, Yongmi An, Zhen-Wei Cai, et al.
Pageof 4